UCLA Clark Urology Center

Los Angeles, California 90095

1 studies enrolling now · 5 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, Cancer of the Prostate, Kidney Neoplasms, Metastatic Castration-Resistant Prostate Cancer, Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, mCRPC

Studies at this site

• A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer — Completed